(c) 2024 PillSync.com

tizanidine 4 mg

1 INDICATIONS AND USAGE Tizanidine tablet is a central alpha-2-adrenergic agonist indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine tablets should be reserved for those daily activities and times when relief of spasticity is most important [see Dosage and Administration (2.1) ]. Tizanidine tablet is a central alpha-2-adrenergic agonist indicated for the management of spasticity. Because of the short duration of therapeutic effect, treatment with tizanidine tablet should be reserved for those daily activities and times when relief of spasticity is most important. (1)

American Health Packaging


9 years ago OVAL WHITE R180 tizanidine 4 mg

OVAL WHITE R180

9 years ago OVAL WHITE R180 tizanidine 4 mg

R180 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING 16.2

TIZANIDINE Tablets

TIZANIDINE Tablets USP, 2 mg are white to off white, oval, flat, beveled edged tablets debossed with “R179” on one side and “bisecting score” on other side. The tablets are available in: Unit dose packages of 30 (5 x 6) NDC 68084-775-25.

TIZANIDINE Tablets USP, 4 mg are white to off white, oval, flat, beveled edged tablets debossed with “R180” on one side and “quadrisecting score” on other side. The tablets are available in: Unit dose packages of 50 (5 x 10) NDC 68084-645-65. Unit dose packages of 100 (10 x 10) NDC 68084-645-01. Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F) [see USP Controlled Room Temperature]. FOR YOUR PROTECTION: Do not use if blister is torn or broken.


More pills like OVAL R180

Related Pills

tizanidine 2 mg

American Health Packaging












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site